- Research article
- Open Access
- Open Peer Review
Periodic cohort health examinations in the TAMRISK study show untoward increases in body mass index and blood pressure during 15 years of follow-up
© Kunnas et al.; licensee BioMed Central Ltd. 2012
- Received: 16 March 2012
- Accepted: 8 August 2012
- Published: 14 August 2012
Obesity is a significant risk factor for hypertension and diabetes. A cohort of 50-year-old voluntary periodic health examination (PHE) participants was analyzed 15 years retrospectively. Our aim was to evaluate changes in body mass index (BMI) and blood pressure in subjects diagnosed with hypertension and/or diabetes in comparison with healthy controls.
Voluntary periodic health examinations (PHE) of the citizens have been carried out by the city of Tampere, Finland. Health data, including body mass index (BMI) and blood pressure, were recorded every five years, starting at the age of 35 (baseline). A total of 339 subjects from the 50-year-old cohort having hypertension and/or diabetes were chosen to the study group. The control group included 604 subjects from the 50-year-old cohort who had the same follow-up information but were not diagnosed with hypertension and/or diabetes.
In the study group the mean BMI had increased from 26.1 at baseline to 28.5 at the final 15-year follow-up examination. The corresponding increase in the control group was from 23.8 at baseline to 25.5 at the final follow-up. The difference in change with time between the groups was statistically significant (p = 0.04). On the average, the controls gained 4.9 kilograms, whereas subjects in the study group gained 7.0 kilograms over the 15 years of follow-up. Systolic and diastolic blood pressures were also higher in the study group already at baseline and systolic blood pressure increased with time more in the study group than in the control group (p = 0.004).
BMI and blood pressure were higher in the study group in comparison with the controls already at baseline at 35 years, and the differences were not favorably changed during the follow-up. Apparently, the effect of PHE had not been as efficient as planned on subjects in the study group, who were already slightly overweight at baseline.
- Periodic health examinations
- Body mass index
Periodic health examinations (PHE) are endorsed as a means of preventive medicine and usually include medical history, physical examination and multiple screening using simple laboratory tests. Goals of PHE are early diagnosis of chronic diseases and the improving of patient understanding of health and disease .
PHE has been a fundamental part of medical practice for decades despite a lack of consensus on its value. In Canada, the roots of the annual PHE date back to 1861. In the 1970s and 1980s, both the Canadian Task Force on the Periodic Health Examination and the United States Preventive Services Task Force recommended abandoning the PHE in favor of regular appropriate evidence-based preventive care during regular visits [2, 3]. A recent systematic review of medical databases suggests that the PHE may lessen patient worry, but other outcomes were vague . It is clear that additional research is needed to assess the costs, benefits and harms as well as long-term outcomes, of the PHE .
Obesity is a significant risk factor for chronic diseases, such as hypertension and diabetes [6–8]. More than 50% of European adults are obese or overweight . We evaluated changes in body mass index (BMI) and blood pressure during 15 years of PHE follow-up. Subjects diagnosed with hypertension and/or diabetes by the age of 50 were compared with controls.
The Tampere adult population cardiovascular risk study (TAMRISK) is a prospective, longitudinal population based health survey study in Tampere, a city in southern Finland with a population of 210 000 [10, 11].
The Tampere city health care centre has provided regular PHEs, for screening and counselling, for the adult population of the city since 1980. All 40- and 50-year-old inhabitants have been invited to participate in these health surveys. During some periods, also 35- and 45-year-olds have been invited to participate. The PHE consisted of one 60-minute session with a public health nurse at the centre's health examination unit. In the session, the questionnaire information and screening tests were reviewed. Counseling was given on topics selected by the participant and also on findings of the screening tests.
Information is available for some participants for 15 years of consecutive 5-year follow-ups concerning risk factors for cardiovascular diseases, including family history, blood pressure, lipid values, smoking, waist circumference, diabetes exercise and eating habits. Also data on diseases has been recorded. Presently, invitations for the survey are sent to all subjects from Tampere that are 40 or 50 years old that year.
All subjects who had a self-reported diagnosis of hypertension and/or diabetes (made by a physician, n = 681) were chosen from a PHE 50-year-old cohort (n = 6000). Those subjects who also had information on 35-, 40-, and 45- year PHE formed the study group (n = 339). The control group included subjects from the same 50-year-old cohort who were apparently healthy, and had the same follow-up information. Controls were chosen for every subject in the study group by matching them according to sex (n = 604). Baseline clinical examinations had taken place during the calendar year when the subject caught the age of 35 in 1988–91. At the age of 40 the same subjects were invited to health examination again if they still lived in Tampere. This happened in 1993–96. The third follow up took place in 1998–2001 at the age of 45. The last follow up was in years 2003–06 at the age of 50. The follow-up time was 15 years. The Ethics Committees of the Tampere University Hospital and the City of Tampere approved the study. Written informed consent for participation in the study was obtained from all participants.
The basic evaluation in 1988–91 included an interview by a public health nurse. The interview was conducted using a structured questionnaire about health and health-related behavior, including questions about current and previous diseases. Information on current and previous diseases was based on self-report of diagnosis by a physician, including history of MI and diabetes. The questionnaire also assessed symptoms and ailments experienced within the past six months. These included questions of health in general and mental health. Questions of health-related behavior included current and past smoking. The frequency of physical exercise comprised both leisure and commute related activity. Quantitative estimation of the alcohol intake was carried out by using three structured questions to determine the amount and frequency of drinking. The total mean consumption of all alcoholic drinks was used, expressed as grams of pure ethanol per week. Physical examination included a single blood pressure (BP) measurement (mm of mercury) using a calibrated mercury sphygmomanometer. Serum total cholesterol (mmoles/liter) was measured by enzymatic techniques. Height (cm) and weight (kg) were recorded from which the body mass index was calculated.
The description of data was made by means and standard deviations for continuous variables and by proportions for categorical variables. The descriptions were constructed separately to the study group and controls. The differences in dichotomous variables were compared with Fisher's exact test, in other categorical variables with Chi-square test and in continuous variables with t-test, or Mann Whitney U test if the distribution was skewed. The analysis of variance for repeated measures was used to assess the differences in changes of body mass index and blood pressure between the study group and the control group during the follow up time. Normality of the distributions of the dependent variables were tested using Kolmogorov-Smirnov test, and logarithmic transformation was applied if the distribution of the variable was skewed. The changes were calculated in relation to the baseline measurement at the age of 40, 45 and 50. The model included the main effects of group factor and time, and their interaction. The baseline measurement of dependent variable was included in the model as a covariate. The risk level in the analyses was set equal to p-value of 0.05. Analyses were made using SPSS for Windows (version 16.0) program.
Background characteristics of subjects examined at baseline in 1988–91 at the age of 35 stratified by whether or not they had hypertension or diabetes (as diagnosed by a physician) by the age of 50
Male gender (%)
In working life (%)
Physical exercise at least 3 times/week (%)
Current daily smokers (%)
Self-reported health status at least quite good (%)
Alcohol consumption as grams/week (SD)
Height (cm), mean (SD)
BMI (kg/m2), mean (SD)
Diastolic BP (mm Hg), mean (SD)
Systolic BP (mm Hg), mean (SD)
Serum cholesterol (mmol/l), mean (SD)
The change in body mass index (BMI) and blood pressure in subjects from the TAMRISK study stratified by whether or not they had hypertension or diabetes by the age of 50
P-value (interaction in change between group and time effects)
Difference (95% CI)
Change in BMI (kg/m2)
40 years of age
45 years of age
50 years of age
Change in systolic blood pressure (mmHg)
40 years of age
45 years of age
50 years of age
Change in diastolic blood pressure (mmHg)
40 years of age
45 years of age
50 years of age
A statistically significant interaction was found in the change of systolic blood pressure between the study group and the controls, and the follow-up time (p = 0.004). The increase was slightly higher in the study group than in the control group. In the study group the highest increase was found between 40 and 45 years of age, whereas in the control group the increase rate was at the highest between the age of 45 and 50.
The diastolic blood pressure remained higher in the study group than in the control group during the follow-up time, but the interaction in the change between the group and the time effects was not statistically significant (p = 0.06). At the age of 50, a total of 61% of the study group were on self-reported blood pressure medication.
A difference was found in the change of BMI between the study group and the control group during the follow-up time. In the study group the increase rate was higher and it was constant over the follow-up time, whereas in the control group the rate slowed slightly during the last 5 years of the follow-up. This suggests that the effects of the PHE had not been efficient enough to stop the weight gain in either group. Especially in the study group the remarkable increase in BMI was seen despite the PHE conducted during the follow-up time and there were no signals of weight gain slowing down.
The subjects in the study group had a higher level of BMI at baseline. Because obesity in known to be a major risk factor for cardiovascular disease and diabetes, the subjects in the study group were in greater risk already on that basis compared with the control group at the very beginning. In that sense it would have been possible to allocate the preventive actions to these subjects in the PHEs. The result suggests that PHE could not intervene with the weight gain of subjects who had a high risk to cardiovascular disease and diabetes.
The increase in blood pressure was in high extent consistent with that of BMI. The blood pressure (both systolic and diastolic) was at higher level in the study group than in the control group already at baseline. The increase in systolic blood pressure was also greater in the study group than in the control group between the ages of 40 and 45. Favorable effects of PHE were not seen in relation to changes in blood pressure, even though blood pressure medication had been started for more than half of the subjects in the study group.
Participant views of the PHE in Tampere have been previously examined in 1995, in a 45-year-old cohort . According to the participants' accounts, the discussions and counseling with a public health nurse had dealt with living habits and, to a lesser extent, with diseases, symptoms and the prevention of illness. Virtually all respondents saw the PHE program as beneficial for everyone. Opinions were divided on its benefits compared with medical help from a physician. Looking at the present results, the PHE, conducted at 5-year intervals by a public health nurse, had not been very effective in intervening with living habits, since BMI continued to increase in the study group, who were already at risk at the age of 35 years. It has been reported that adults who were overweight but not obese (i.e., 25.0 ≤ BMI ≤ 29.9) were at significantly increased risk of developing numerous health conditions, such as diabetes, gallstones, hypertension, heart disease, and stroke . Although the study group had a diagnosis of diabetes or hypertension by a physician, their medical intervention was not sufficient in terms of blood pressure medication. Certainly a larger proportion of cases would have been in need for more regular intervention and medication.
At the age of 35, subjects in the study group used more alcohol per week (95 g) than controls (79 g). This alcohol consumption should be considered in the context that self-reporting of drinking is commonly unreliable and the official per capita mean consumption of absolute ethanol in Finland for inhabitants 15 years and older is 8.4 l per year, corresponding to 162 g per week . Since physical activity was not different between the study group and controls, the difference in alcohol intake has potential to explain the remarkable increase of BMI in the study group compared to controls during the follow-up time.
The strength of present study is the large cohort from which the data was collected. The data analyzed included 943 subjects all born in the four year period 1951–54 and followed up for 15 years. Thus there was no confounding by age. The 15-year follow-up of the cohort enables to study trends in health factors. However, since the study group was restricted to residents of a large city in Finland poses a challenge to how broadly one can apply the findings. Because the studied population represented only Caucasians, our findings cannot be generalized to minority groups.
The unfavorable differences in BMI and blood pressure between the study group, who had hypertension and/or diabetes at the age of 50, and the controls were seen already at the 35-year-old PHE and they were not corrected during the 15-year follow-up time when PHE were conducted. This suggests that the effect of PHE had not been as favorable as desired among the subjects in the study group, who were at risk already at the age of 35.
This study was supported by grants from Competitive research funding of the Pirkanmaa Hospital District and the Finnish Cultural Foundation.
- Breslow L: Prevention and control of chronic disease. V. Periodic health examination and multiple screening. Am J Public Health Nations Health. 1959, 49: 1148-1156. 10.2105/AJPH.49.9.1148.View ArticlePubMedPubMed CentralGoogle Scholar
- Hayward RS, Steinberg EP, Ford DE, Roizen MF, Roach KW: Preventive care guidelines: 1991. American College of Physicians. Canadian Task Force on the Periodic Health Examination. United States Preventive Services Task Force. Ann Intern Med. 1991, 114: 758-783.View ArticlePubMedGoogle Scholar
- Howard-Tripp M: Should we abandon the periodic health examination?: YES. Can Fam Physician. 2011, 57: 158-160.PubMedPubMed CentralGoogle Scholar
- Boulware LE, Marinopoulos S, Phillips KA, Hwang CW, Maynor K, Merenstein D, Wilson RF, Barnes GJ, Bass EB, Powe NR, Daumit GL: Systematic review: the value of the periodic health evaluation. Ann Intern Med. 2007, 146: 289-300.View ArticlePubMedGoogle Scholar
- Mavriplis CA: Should we abandon the periodic health examination?: NO. Can Fam Physician. 2011, 57: 159-161.PubMedPubMed CentralGoogle Scholar
- Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA: Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period. Arch Intern Med. 2001, 161: 1581-1586. 10.1001/archinte.161.13.1581.View ArticlePubMedGoogle Scholar
- Davin C, Vollenweider P, Waeber G, Paccaud F, Marguese-Vidal P: Cardiovascular risk factors attributable to obesity and overweight in Switzerland. Nutr Metab Cardiovasc Dis. 2011, [Epub ahead of print]Google Scholar
- Nejat EJ, Polotsky AJ, Pal L: Predictors of chronic disease at midlife and beyond – the health risks of obesity. Maturitas. 2010, 65: 106-111. 10.1016/j.maturitas.2009.09.006.View ArticlePubMedGoogle Scholar
- Hyde R: Europe battles with obesity. The Lancet. 2008, 371: 2160-2161. 10.1016/S0140-6736(08)60936-8.View ArticleGoogle Scholar
- Kunnas T, Solakivi T, Huuskonen K, Kalela A, Renko J, Nikkari ST: Hematocrit and the risk of coronary heart disease mortality in the TAMRISK study, a 28-year follow-up. Prev Med. 2009, 49: 45-47. 10.1016/j.ypmed.2009.04.015.View ArticlePubMedGoogle Scholar
- Kunnas T, Solakivi T, Renko J, Kalela A, Nikkari ST: Late-life coronary heart disease mortality of Finnish war veterans in the TAMRISK study, a 28-year follow-up. BMC Public Health. 2011, 11: 71-10.1186/1471-2458-11-71.View ArticlePubMedPubMed CentralGoogle Scholar
- Nupponen R: Client views on periodic health examinations: opinions and personal experience. J Adv Nurs. 1996, 23: 521-527. 10.1111/j.1365-2648.1996.tb00014.x.View ArticlePubMedGoogle Scholar
- Holder HD, Giesbrecht N, Horverak O, Nordlund S, Norström T, Olsson O, Osterberg E, Skog OJ: Potential consequences from possible changes to Nordic retail alcohol monopolies resulting from European Union membership. Addiction. 1995, 90: 1603-1618. 10.1111/j.1360-0443.1995.tb02831.x.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/12/654/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.